ASIA Travel

Finnair Cargo Earns IATA’s Pharma Certificate

Home Search Send to Friend Latest Travel News Asia Thursday, 2 July 2015

Finnair Cargo has passed IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics program (CEIV Pharma).

Finnair joined the program under the successful Brussels Airport CEIV Pharma Community approach, as Brussels is Finnair Cargo's second hub.

Pharmaceuticals are among the most delicate products transported as air cargo, and therefore it is essential to ensure their transport follows a global standard and strict temperature control guidelines.

“We are committed to be at the forefront in the fast growing Pharma transport segment and provide excellent service to our customers. Therefore, we are honored to be the first carrier in the world to complete the IATA pharmaceutical certification process," said Juha Järvinen, Finnair’s Chief Commercial Officer.

The certificate was presented to Finnair Cargo in conjunction of the laying of the cornerstone of Finnair’s new cargo terminal, the COOL Nordic Cargo (CNC) hub. The new state-of-the-art terminal will feature separate temperature controlled areas for the handling of Pharmaceuticals as well as other perishables foodstuffs.

Rafael Schvartzman, IATA’s Regional Vice President for Europe, said, “We are delighted to recognize Finnair and its HEL station as CEIV Pharma Certified – the first airline to complete this process. From its state-of-the-art facility, excellent quality management system, well-trained workforce, and certifications, Finnair has raised the bar high for the rest to follow. I congratulate Finnair on this achievement”

See other recent news regarding: Interviews, Pictures, Videos, Finnair, IATA, Cargo, Freight, Pharma

Subscribe to our Latest Travel News Daily Email Free of Charge by simply entering your email address to the right. You can also receive the daily news service by WhatsApp, stay updated with our RSS Feed Free Travel News RSS Feed and even add the travel news to your website. Have questions? Please read our travel news FAQ.
Copyright © 1997-2020